Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.
The following list is consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia may not participate in every one however the list is updated regularly.
If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia at email@example.com or on (03) 9662 9420.
|NEW VISA SCHEME FOR AUSTRALIA
Due 15 September 2017
|The Government tasked the Department of Immigration and Border Protection with transforming Australia’s visa system to make it easier to understand, easier to navigate and more responsive to our economic, social and security interests.
Australia’s visa system has not been significantly changed for almost 30 years. Over that time, global migration patterns have changed and so have Australia’s needs. Australia’s visa system is in many respects an artefact of a bygone era and is ill suited to this future. The visa system is highly complex, with 99 individual visa types.
The Department is seeking submissions on visa simplification. Key areas for consideration include:
·the scope for a reduction in the number of visas from 99 to approximately ten;
·the delineation between temporary entry and long-term or permanent residence; and
·ensuring that our visa system supports Australia as a competitive and attractive destination for temporary and longer-term entrants.
The Department has released a policy consultation paper to support stakeholders in developing their response.
|REVIEW OF NATIONAL GENE TECHNOLOGY REGULATORY SCHEME
Due 15 September 2017
|The Gene Technology Regulatory Scheme consists of the Gene Technology Act 2000 and the Gene Technology Regulations 2001 and corresponding state and territory laws to provide a nationally consistent system to regulate development and use of gene technology in Australia.
The Scheme is now the subject of a review. This first stage of the consultation process is to better understand the ideas, key issues and views of stakeholders.
Submissions are to be provided based on the Terms of Reference for the Review. A Background Paper has been developed for consideration in making a submission. The purpose of this paper is to provide background and contextual information.
|WA SUSTAINABLE HEALTH REVIEW
Due 2 October 2017
|Submissions are sought from all members of the community, including people and organisations within the WA health system, who would like to share their experiences and perspectives on how to harness new ideas, technology and innovation to ensure the Western Australian Government can continue to deliver high-quality healthcare into the future. The terms of reference are available from the website.|